TITAN TIMI 34

OBJECTIVE: To evaluate a novel anti-ischemic agent, ranolazine, in patients with acute coronary syndromes.

View/Download
_______________________________________________________________________________

1. Early initiation of eptifibatide in the emergency department before primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: results of the Time to Integrilin Therapy in Acute Myocardial Infarction (TITAN)-TIMI 34 trial. Gibson CM, Kirtane AJ, Murphy SA, et al. Am Heart J 2006;152:668-75.
   | Abstract | Request Reprints |
   

2. Impact of iodinated contrast injections on percent diameter coronary arterial stenosis and implications for trials of intracoronary pharmacotherapies in patients with ST-elevation myocardial infarction. Gibson CM, Buros J, Ciaglo LN, et al. Am J Cardiol 2007;100:13-7.
   | Abstract | Request Reprints |